The U.S. restricted access barrier system market size was valued at USD 172.8 million in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 4.7% from 2020 to 2028. Increasing demand for modular containment systems, growing biotechnological industry, and rising investments in R&D in the field of biotechnology are expected to drive the market in the U.S. The chemical industry in the U.S. is regaining its lost momentum after the disruptions of the supply chain, plummeting demand, and the negative effects of the COVID-19 pandemic. The demand for a restricted access barrier system (RABS) is likely to witness growth on account of the improving consumer demand, growing shale and natural gas sector, and stabilizing global exports.
The pandemic has led the U.S. government to promote local manufacturing of pharmaceuticals, especially active pharmaceutical ingredients (APIs), which require RABS during manufacturing. This has resulted in augmenting the demand for aseptic manufacturing facilities complementing the market growth in the U.S.
The demand for RABS is expected to witness growth in medical applications owing to its ability to provide septic safety in the critical zone and flexibility for interventions. In addition, efficiency and low capital investment compared to cleanrooms and isolators are anticipated to propel the demand for RABS in the near future.
The chemical industry extensively utilizes RABS for developing new chemicals and manufacturing fine chemicals. RABS is used to prevent the contamination of chemicals, which may hamper the reaction during the manufacture of chemicals and protect the workers that are handling toxic and hazardous chemicals. The growing demand for RABS from the chemical industry is expected to create upswings for the market growth over the forecast period.
RABS are usually cleaned manually followed by a CIP (Clean in Place) unit to clean up commodities. This process is simpler than the cleaning process of isolators, which includes bio-decontamination, which, in turn, is expected to boost the demand for RABS in aseptic filling systems over the forecast period.
The pharmaceutical segment led the market and accounted for 64.5% share in 2020. Most pharmacies prefer RABS over isolators as they are faster in the changeover process. RABS air handling is easier as compared to isolators as they use recycled and re-circulated air. The aforementioned factors are expected to boost the market growth in the U.S.
The medical application segment is expected to expand at a CAGR of 3.9% over the forecast period owing to its ability to provide septic safety in the critical zone and flexibility for interventions. In addition, efficiency and low capital investment compared to cleanrooms and isolators are anticipated to propel the demand for RABS over the forecast period.
Maintaining aseptic conditions in the chemical industry is significant in order to avoid contamination of the product. The RABS setup provides dynamic airflow protection and physical barrier. In the U.S., from the beginning of 2021, the production of chemicals has normalized resulting in the rapid growth of the chemical industry, which is beneficial for the RABS market.
A restricted access barrier system is used in the electrical as well as cosmetic and personal care industries. Manufacturers of cosmetics and personal care products in the U.S. are focusing on using high-quality raw materials as well as consumer safety, resulting in boosting the demand for sterile conditions using RABS in the filling and packaging of the products.
The competitive environment in the market is driven by innovation in technology used in restricted access barrier systems. Companies operating in the market are investing significantly in R&D to reduce decontamination cycle time and promote better air handling. The growing demand for fill-finish processing across the globe has compelled manufacturers to form alliances with end-users for the application of RABS.
The presence of a few established global market players in the U.S. market, coupled with the rising demand for extensive R&D in the field of barrier technologies, is expected to increase competition among the market players. Increasing collaborations with contract manufacturers are expected to result in a high competitive rivalry in the market over the coming years. Some prominent players in the U.S. restricted access barrier system market include:
I.M.A. Industria Macchine Automatiche S.P.A.
Germfree Laboratories, Inc.
AZBIL TELSTAR, S.L.U.
Syntegon Technologies GmbH
Isolation Systems Inc.
Shanghai Tofflon Science and Technology Co., Ltd.
Ortner Reinraumtechnik GmbH
Market size value in 2021
USD 181.9 million
Revenue forecast in 2028
USD 249.4 million
CAGR of 4.7% from 2020 to 2028
Base year for estimation
2017 - 2019
2020 - 2028
Revenue in USD million and CAGR from 2020 to 2028
Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Key companies profiled
I.M.A. Industria Macchine Automatiche S.P.A.; Germfree Laboratories, Inc.; Extract Technology; AZBIL TELSTAR, S.L.U.; Syntegon Technologies GmbH; Isolation Systems Inc.; Shanghai Tofflon Science and Technology Co., Ltd.; Ortner Reinraumtechnik GmbH; COMECER S.p.A.; SKAN AG
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country & segment scope.
Pricing and purchase options
Avail customized purchase options to meet your exact research needs. Explore purchase options
This report forecasts revenue growth at the country level and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2017 to 2028. For the purpose of this study, Grand View Research has segmented the U.S. restricted access barrier system market report on the basis of application:
Application Outlook (Revenue, USD Million, 2017 - 2028)
b. The U.S. restricted access barrier system market size was estimated at USD 172.8 million in 2020 and is expected to reach USD 181.9 million in 2021
b. The U.S.RABS market, in terms of revenue, is expected to grow at a compound annual growth rate of 4.7% from 2020 to 2028 to reach USD 249.4 million by 2028
b. The pharmaceutical application segment dominated the RABS market with a revenue share of 64.5% in 2020, owing to the growing pharmaceutical industry in the U.S. coupled with advantages such as a faster changeover process and easy handling
b. Some of the key players operating in the U.S. restricted access barrier system market include I.M.A. Industria Macchine Automatiche S.P.A., Germfree Laboratories, Inc., Extract Technology, AZBIL TELSTAR, S.L.U., Syntegon Technologies GmbH, COMECER S.p.A., SKAN AG among others
b. The key factors driving the U.S. restricted access barrier system market include technological advancements, an increasing number of small-scale biopharma companies, and rising investments in research & development activities
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now
"The quality of research they have done for us has been excellent."